Objective Coronary atherosclerosis has been associated with systemic arterial remodeling even in nonatherosclerotic vessels. However, it is not known whether systemic remodeling is differentially associated with the cumulative atherosclerotic process, reflected by putatively quiescent calcified plaque (CP), or with active atherosclerosis, consisting of noncalcified plaque (NCP). We thus examined the association of brachial artery diameter (BAD), an artery that does not suffer clinical atherosclerosis, with the presence and the extent of coronary CP and NCP.
Introduction
Although the brachial artery does not develop clinically obstructive atherosclerosis [1] , autopsy studies demonstrate low-grade atherosclerotic lesions concomitant with more severe atherosclerotic disease in other vascular beds such as the coronary arteries [2] . The external remodeling and arterial enlargement of atherosclerotic vascular segments, for example the coronary arteries [3] , is thought to be adaptive for the maintenance of a localized shear rate [4] . There is also evidence that atherosclerosis in one arterial bed may be associated with systemic arterial remodeling, including the brachial artery [5] [6] [7] . A greater brachial artery diameter (BAD) has been shown to be associated with the Framingham Risk Score [8] and with cardiovascular events [9] . With aging, larger BAD is accompanied by a maladaptive lower shear rate [10] . It is at present unknown whether the cumulative atherosclerotic process or a currently active level of atherosclerosis is associated with systemic arterial remodeling.
We hypothesized that localized active coronary atherosclerosis may result in maladaptive remodeling of arteries throughout the vascular system, including the brachial arteries. Early active stages of coronary atherosclerosis are characterized by noncalcified plaques (NCPs) composed of lipid, inflammatory cells, and fibrous tissue [11, 12] that may be prone to rupture, thrombosis, and coronary artery disease (CAD) events [13, 14] , whereas later stages show plaque calcification, reflecting a relative quiescence of the pathogenic process [15] . Thus, we further hypothesize that BAD should be associated with NCP rather than with calcified plaque (CP).
Methods

Sample population
The sample population (n = 688) was recruited from the ongoing GeneSTAR (Genetic Study of Atherosclerosis Risk) cohort. Probands with early-onset CAD before the age of 60 years (myocardial infarction, unstable angina requiring revascularization, or acute angina with angiographic evidence of >50% stenosis in any coronary artery) were identified in 10 Baltimore-area hospitals. Apparently healthy, asymptomatic family members of the proband were invited to participate, including siblings of the proband and offspring of the proband or of the siblings. Individuals with known CAD, systemic autoimmune disease, chronic kidney failure, or allergy to iodinated dyes were excluded. The study was approved by the Johns Hopkins Institutional Review Board, and all participants provided informed consent.
Risk factor assessment
Participants underwent a comprehensive risk factor assessment after a 12-h overnight fast. Medical history and current medication use were elicited, and a physical examination was performed by a study cardiologist. Medication use was confirmed by examining prescription medication containers brought in by the participants. Current cigarette smoking behavior was assessed by selfreport and verified by expired carbon monoxide levels of at least 8 ppm. Height and weight were measured with light clothing and without shoes on a stadiometer. BMI was calculated as weight/height 2 . Seated blood pressure was obtained using JNC VI guidelines [16] as an average of three readings over the course of the screening day. Hypertension was defined as a mean blood pressure of at least 140 mmHg systolic or at least 90 mmHg diastolic and/or by the use of antihypertensive medication. Blood was obtained for measurement of lipid and glucose levels. Total cholesterol, HDL cholesterol, and triglyceride levels were measured using the United States Centers for Disease Control standardized methods [17] . LDL cholesterol was estimated using the Friedewald formula [18] for individuals with triglyceride levels of up to 400 mg/dl. Diabetes was defined as a measured fasting glucose level of at least 126 mg/dl and/or use of hypoglycemic medication.
Computed tomography methods
Computed tomographic angiography was performed using the newest generation dual-source multidetector scanner (SOMATOM Definition Flash; Siemens Medical Solutions, Forchheim, Germany). Both noncontrast and contrast-enhanced images were acquired. The volume of CP was measured on a workstation (Leonardo Multimodality Workstation, Syngo; Siemens Medical Solutions, Malvern, Pennsylvania, USA) using noncontrast images. Regions of interest were placed over each of the coronary arteries and a threshold greater than 130 HU was used for determining per vessel volumes of CP (mm 3 ) using standard validated methods [19, 20] . Vessel CP volumes were summed for a total CP volume. NCP volumes were quantified from contrast-enhanced images using a wellvalidated automated software (AUTOPLAQ; Cedars-Sinai Medical Center, Los Angeles, California, USA) as described previously [21] .
Ultrasound methods
Brachial artery 2D B-mode ultrasound imaging was performed using a Philips CX50 Ultrasound machine with a 12-3 MHz linear probe (Philips Healthcare, Bethesda, Maryland, USA). Video images were digitized at 29 frames/s. The brachial artery interadventitial diameter was measured in a 5-mm region of interest using an automated edge detection software (Brachial Tools; Medical Imaging Applications, Coralville, Iowa, USA) for a period of 20 s. Diastolic frames were identified as local minima in the diameter versus time signal. The average diastolic diameter was used for this analysis.
Statistical methods
Descriptive analysis
We tabulated demographic and risk factor characteristics by quintile of BAD. In addition to unadjusted tests using analysis of variance for continuous variables and w 2 -tests for categorical variables, we tabulated age-adjusted, sexadjusted, and race-adjusted P-values using generalized estimating equation (GEE) models to correct for intrafamilial correlation. We examined the tetrachoric correlation coefficient between the dichotomized variables of any CP and any NCP, as well as the Spearman correlation between CP and NCP volumes in the subset of individuals with any detectable plaque.
Association analysis
For association of linear trend, the sample was divided into six groups by plaque volume. Separate groups were defined for CP and NCP. The groups were group 1, no detectable plaque, and groups 2-6, quintiles for NCP or CP if any plaque was detectable. The group ranges for NCP volume were 0, 3-50.5, 50.7-98.7, 98.9-168.2, 173.9-310.6, and 315.4-1063.6 mm 3 . The group ranges for CP volume were 0, 0.1-8.0, 8.1-26.9, 27.4-69.5, 70.4-227.6, and 239-1909.7 mm 3 . Medians and interquartile ranges were graphed by sex, and age-adjusted and race-adjusted trends were tested using GEE.
Multivariable-adjusted analysis with both CP and NCP volumes in the same model was performed using GEE adjusting for sex, age, race, smoking, hypertension, diabetes, BMI, HDL cholesterol, and non-HDL cholesterol.
Sensitivity analysis
We performed multivariate analysis adjusting for (a) systolic blood pressure and blood pressure medication use, (b) aspirin use, and (c) height and weight as separate covariates, and (d) using a spline model with a different covariate for any plaque and for the volume of plaque subtype if any plaque was present.
Results
Sample characteristics
In this sample, 385 (56%) individuals had no detectable coronary plaque, eight (1%) had exclusively NCP, 41 (6%) had exclusively CP, and 254 (37%) had mixed plaque. The tetrachoric (dichotomous) correlation between the prevalence of CP and NCP was 0.98 (P < 0.001), whereas the Spearman correlation between NCP and CP volumes among those with detectable plaque was 0.66 (P < 0.001). The distribution of demographic and cardiovascular risk factor characteristics in the sample population are shown in Table 1 . Older ages and male sex were associated with higher quintiles of BAD. After adjustment for age and sex, hypertension, lower levels of HDL-C, and greater BMI were associated with higher quintiles of BAD.
Association of plaque and plaque volumes with brachial artery quintiles Figures 1 and 2 show the median and interquartile ranges of BAD by NCP and CP groups. Although the unadjusted trend of greater BAD with greater plaque volume was significant for NCP and CP in both sexes (P < 0.002 for all), after age and race adjustment only higher levels of NCP remained significantly associated with a larger BAD (women, P = 0.032 and men, P = 0.023), whereas CP levels were no longer associated with BAD (women, P = 0.50 and men, P = 0.15). Table 2 shows the multivariable GEE regression analysis for BAD. Male sex, older age, and higher BMI were significantly associated with a larger BAD. In addition, every 1 ml greater volume of NCP was associated with a 0.67 mm larger BAD (P = 0.027). No significant association was found between BAD and CP volumes.
Multivariate regression analysis
Sensitivity analyses
The association of NCP volume with BAD remained significant and the association of CP volume with BAD remained nonsignificant in the multivariate analysis adjusting for (a) systolic blood pressure and blood pressure medication use, (b) aspirin use, and (c) height and weight as separate covariates, and (d) using a spline model with a different covariate for any plaque and for the volume of plaque subtype if any plaque was present.
Discussion
To our knowledge, this is the first study to show the association between noncalcified but not calcified coronary plaque volumes and BAD, after adjustment for age, sex, and race. We found that the unadjusted association of BAD with the presence of any plaque and CP was explained successively by age and cardiovascular risk factors, suggesting that the associations of BAD with these plaque characteristics are cumulative over a long period and are not specific. However, we also found that the association of BAD with NCP was only partially explained with age and was not attenuated further on adjustment for cardiovascular risk factors, suggesting that the degree of active coronary atherosclerosis may have systemic effects on other arterial beds.
NCP volume represents a measure of currently active and vulnerable atherosclerotic processes [11] [12] [13] [14] ; thus, this independent association with BAD likely represents a current and dynamic systemic process. A recent study showing that maladaptive BAD enlargement in severe obesity was reversible with weight loss supports the suggestion that arterial remodeling is a dynamic process [22] . Other studies have found associations of BAD with CAD phenotypes. Larger BADs have been associated with atherosclerotic risk factors including age and the Framingham Risk Score [8, 10] . In longitudinal studies, BAD has been associated with cardiovascular events [9] . Rohani et al. [7] found that BAD was associated with angiographically determined extents and severities of coronary stenoses in symptomatic individuals. In the Cardiovascular Health Study, BAD was associated with the presence, but not the extent, of coronary calcification measured using the Agatston score [6] . This is consistent with our findings demonstrating an extremely high correlation between the presence of CP and NCP; however, the correlation between the extent of NCP and CP plaque volumes, if present, was low.
External remodeling at the site of atherosclerotic plaque is an adaptive response to prevent local stenoses [3] .
Although autopsy studies show that brachial arteries do undergo early-stage atherosclerosis [2] , lesions in the brachial artery do not develop into clinically significant stenoses [1] . In addition, these early-stage brachial artery lesions have been correlated with more severe carotid lesions [2] , supporting the concept that severe lesion Brachial artery diameter (mm)
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Median and interquartile ranges of brachial artery diameter by noncalcified plaque volume (volume ranges of groups: 0, 3-50.5, 50.7-98.7, 98.9-168.2, 173.9-310.6, and 315.4-1063.6 mm 3 ). Age-adjusted and race-adjusted trends for women, P = 0.032; men, P = 0.023. NCP, noncalcified plaque. progression may depend on local hemodynamics but other arterial beds may be affected by systemic changes that occur from the atherosclerotic process. A larger carotid artery diameter has also been shown to be associated with aging and cardiovascular risk factors [23] . Other studies have shown that BAD is associated with carotid artery diameter and left [24] and right ventricular mass [25] .
Atherosclerosis is now known to be an inflammatory process, with evidence of circulating inflammatory mediators and activated inflammatory cells, especially monocytes. External remodeling of nonatherosclerotic arterial segments are dependent on macrophage activation and the action of proteases such as matrix metalloproteinases on the adventitial extracellular matrix [26] . It is not known whether brachial artery remodeling occurs because of cell activation and protease secretion in distant active atherosclerotic lesions or because of local cell activation. Our study shows that BAD is correlated with the volume of putatively active NCP in a different vascular bed, suggesting that inflammatory atherosclerotic processes in one vascular bed may affect the whole circulatory system. Alternatively, even though the brachial artery does not show lesions, low-grade inflammatory processes may be present within these arteries and a larger BAD may signify a general systemic vasculopathy.
We found that BAD is not associated with the volume of CP, which is presumably quiescent as compared with NCP. The volume of CP represents the cumulative burden of atherosclerotic processes throughout the lifetime. This suggests that systemic arterial remodeling is a dynamic phenomenon that depends on currently active atherosclerotic processes. This warrants a future longitudinal study to determine whether BAD regresses or progresses along with atherosclerotic activity in clinically relevant vascular beds.
The advanced computed tomographic angiography imaging technology that makes it possible to distinguish CP and NCPs and the reproducible automated quantitation of plaque volumes are the strengths of our study, as is the wide age range of men and women in this biracial sample. The ascertainment of our sample from families with a history of premature CAD may be responsible for adequate prevalence of coronary plaque to be able to perform association analyses. This strength could be a partial limitation in generalizing our findings to non-highrisk family populations. However, our study recapitulates BAD associations with age and other risk factors seen in prior studies. Thus, we believe that our findings may be cautiously applicable to the general population.
Conclusion
We have found that the diameter of the brachial artery, which is a measure of the extent of external remodeling of systemic arteries not undergoing local clinical atherosclerosis, is associated with a putatively active plaque burden in distant coronary arterial beds, but not with the volume of quiescent CP. This suggests that atherosclerosis is a process with systemic effects in terms of remodeling and that such a remodeling process is likely to be dynamic and not cumulative over the lifetime. 
